Results 141 to 150 of about 27,057 (223)

Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study. [PDF]

Ann Hematol
Cavalca F, Latagliata R, Pugliese N, Palumbo GA, Polverelli N, Musto P, Benevolo G, Branzanti F, Di Veroli A, Buttini EA, Ripamonti A, Civettini I, Montelisciani L, Antolini L, Gambacorti-Passerini C, Palandri F, Elli EM.   +16 more
europepmc   +1 more source

Chronic Inflammation in Primary Myelofibrosis: In-Depth Insights Into Pathogenesis and Promising Anti-Inflammatory Therapeutic Strategies. [PDF]

Mediators Inflamm
Chen M, Zheng C, Zhang Y, He J, Shi Z.
europepmc   +1 more source

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial. [PDF]

Hematol Oncol
Melo Campos P, Pagnano KBB, Niemann FS, Mancuso RI, Della Via FI, Congrains A, Coelho-Silva JL, Tinoco ÂC, Assis-Mendonça GR, Freitas LLL, Traina F, Saad STO.   +11 more
europepmc   +1 more source

Inhibiting the alarmin-driven hematopoiesis-stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis. [PDF]

Hemasphere
Gleitz HFE, Fuchs SNR, Snoeren IAM, Boys C, Nagai J, Tejeda-Mora H, Klöker V, Pritchard JE, Bakker IJ, Gargallo Garasa M, Bindels E, Saez-Rodriguez J, Vogl T, Kramann R, Dugourd A, Costa IG, Schneider RK.   +16 more
europepmc   +1 more source

Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis. [PDF]

Blood Adv
Luque Paz D, Gagelmann N, Benajiba L, Riou J, Salit R, Orvain C, Schroeder T, Bories C, Gurnari C, Badbaran A, Boyer F, Pagliuca S, Rautenberg C, Tavitian S, Pangiota V, Ianotto JC, Thol F, Cayssials E, Heuser M, Rubio MT, Cassinat B, Daltro de Oliveira R, Sauter C, Maciejewski JP, Reinhardt HC, Scott BL, Ugo V, Kröger N, Kiladjian JJ, Robin M.   +29 more
europepmc   +1 more source

Primary myelofibrosis in rheumatic diseases

Научно-практическая ревматология, 2013
Vladimir Ivanovich Vasilyev, V R Gorodetsky, S Kh Sedyshev, O A Logvinenko, N A Probatova, A I Pavlovskaya, M S Eliseyev, A V Smirnov, G R Fadienko   +8 more
doaj   +1 more source

Basophilia and eosinophilia in primary myelofibrosis: phenotype, genotype, and prognostic correlates. [PDF]

Blood Cancer J
Dingli S, Fathima S, Faldu P, Gangat N, Dingli D, Tefferi A.   +5 more
europepmc   +1 more source

Valore predittivo di variabili clinico-laboratoristiche in pazienti con mielofibrosi trattati con inibitore di JAK-1/2 [PDF]

, 2011
CARAMAZZA, Domenica
core  

Overt Primary Myelofibrosis [PDF]

, 2020
openaire   +1 more source

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system

Drugs in Context, 2019
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Marisante Napolitano , Florinda Di Piazza, Antonio Russo, Sergio Mario Siragusa   +6 more
doaj   +1 more source